Certain advantages of analogue I are enhanced chemical and proteolytic stability, less MAP drop after administration, and a clear trend towards better metabolic preservation of postischemic cardiomyocytes.
← all excerpts
Effects of structural analogues of apelin-12 in acute myocardial infarction in rats.
1
—
—